IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i21p7835-d434896.html
   My bibliography  Save this article

Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances

Author

Listed:
  • Hassan Zgheib

    (UMR Transfrontalière BioEcoAgro1158, Univ. Lille, INRAE, Univ. Liège, UPJV, YNCREA, Univ. Artois, Univ. Littoral Côte d’Opale, ICV–Institut Charles Viollette, 59000 Lille, France
    Univ. Lille, CNRS, Centrale Lille, Univ. Polytechnique Hauts-de-France. UMR 8520–IEMN, 59000 Lille, France)

  • Djamel Drider

    (UMR Transfrontalière BioEcoAgro1158, Univ. Lille, INRAE, Univ. Liège, UPJV, YNCREA, Univ. Artois, Univ. Littoral Côte d’Opale, ICV–Institut Charles Viollette, 59000 Lille, France)

  • Yanath Belguesmia

    (UMR Transfrontalière BioEcoAgro1158, Univ. Lille, INRAE, Univ. Liège, UPJV, YNCREA, Univ. Artois, Univ. Littoral Côte d’Opale, ICV–Institut Charles Viollette, 59000 Lille, France)

Abstract

Bacteriocins are antimicrobial peptides some of which are endowed with antiviral, anticancer and antibiofilm properties. These properties could be improved through synergistic interactions of these bacteriocins with other bioactive molecules such as antibiotics, phages, nanoparticles and essential oils. A number of studies are steadily reporting the effects of these combinations as new and potential therapeutic strategies in the future, as they may offer many incentives over existing therapies. In particular, bacteriocins can benefit from combination with nanoparticles which can improve their stability and solubility, and protect them from enzymatic degradation, reduce their interactions with other molecules and improve their bioavailability. Furthermore, the combination of bacteriocins with other antimicrobials is foreseen as a way to reduce the development of antibiotic resistance due to the involvement of several modes of action. Another relevant advantage of these synergistic combinations is that it decreases the concentration of each antimicrobial component, thereby reducing their side effects such as their toxicity. In addition, combination can extend the utility of bacteriocins as antiviral or anticancer agents. Thus, in this review, we report and discuss the synergistic effects of bacteriocin combinations as medicines, and also for other diverse applications including, antiviral, antispoilage, anticancer and antibiofilms.

Suggested Citation

  • Hassan Zgheib & Djamel Drider & Yanath Belguesmia, 2020. "Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances," IJERPH, MDPI, vol. 17(21), pages 1-12, October.
    • Handle: RePEc:gam:jijerp:v:17:y:2020:i:21:p:7835-:d:434896
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/21/7835/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/21/7835/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Pachiyappan Kamarajan & Takayuki Hayami & Bibiana Matte & Yang Liu & Theodora Danciu & Ayyalusamy Ramamoorthy & Francis Worden & Sunil Kapila & Yvonne Kapila, 2015. "Nisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-20, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Clémence Loiseau & Jacques Augenstreich & Adrienne Marchand & Etienne Harté & Martine Garcia & Julien Verdon & Marc Mesnil & Sophie Lecomte & Jean-Marc Berjeaud, 2016. "Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging," PLOS ONE, Public Library of Science, vol. 11(9), pages 1-15, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:21:p:7835-:d:434896. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.